1. Pink Sheet
  2. >>Agency Leadership

Oncology Center Of Excellence Deputy Directors Kluetz, Theoret Join US FDA Exodus

 
• By Sue Sutter and Sarah Karlin-Smith

The April departures of Paul Kluetz and Marc Theoret follow resignations by other senior agency scientific staff and come on top of HHS’ plans to lay off 3,500 FDA employees.

Exit sign
Voluntary departures are adding to the loss due to layoffs, early retirements and buyouts. (Shutterstock)

Voluntary departures at the US Food and Drug Administration, including two senior staff in the Oncology Center of Excellence, will compound the personnel chaos expected from large-scale reductions-in-force ordered by the Health and Human Services Department.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA

More from Agency Leadership